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Despite our best efforts to safely manage all the new drugs on the market, and the
complex therapies for the burgeoning elderly population and chronically ill, mistakes
occur each day in every kind of health care setting. The extent of this problem was
revealed in the Institute of Medicine’s (IOM) report To Err is Human, which estimated
that at least 7,000 patients were dying each year from preventable medication errors.1
For 30 years, the USP-ISMP Medication Errors Reporting Program, operated jointly by
the United States Pharmacopeia and the Institute for Safe Medication Practices, has
provided compelling evidence of medication-use system failures through analysis of
voluntary reports. The program has alerted the health care industry to hazardous
conditions that have frequently linked ordering, dispensing, and administration errors to
ambiguous and illegible handwritten prescriptions; look- and sound-alike drug names;
and poorly designed labeling. Despite these and other well-known system-related issues,
the majority of the public, media, regulatory boards, and even some health care leaders
continue to believe that accountability for error prevention lies solely with front-line
practitioners, where the caregiver/patient interactions occur.
James Reason, the “grandfather” of human errors and architect of the “Swiss cheese
model” of error, believed that errors are never the result of a single failure but, instead, a
series of system breakdowns, most of which are outside the control of the individual.2
The Reason model also rejects naming, blaming, and training the practitioner closest to
an error since this allows other key stakeholders to inappropriately delegate responsibility
for the error back to that individual. A safe medication-use system requires early
identification of problems, initiation of practical safety solutions, and universal
acceptance of shared accountability among all stakeholders.3 It is paramount that health
care professionals, organizations, product vendors, academic professionals, regulatory
authorities, the media, health policy leaders, and even patients do their part to ensure a
safe medication-use system.
The IOM’s recent report, Preventing Medication Errors outlines the actions that
stakeholders should take, including a comprehensive examination of problems within the
system and important safety strategies and policies needed for prevention.4 Listed below
are a just a few of the essential actions for which stakeholders should be held
accountable.

Practitioners
Individual must speak out about patient safety issues, voluntarily report errors, near
misses, and hazardous situations to internal and external programs, and share personal
knowledge of what went wrong when an error occurs. Further, practitioners need to
maintain competencies, stay abreast of current medication safety literature, and make the
necessary changes in practice when safety recommendations are offered.
Health Care Leaders and Organizations
Organizations need to incorporate patient safety into their mission statement and uphold
practice issues. The affirmation that patient safety is “Job #1” must be accompanied by
genuine action and financial commitment to a safe medication-use system. Leaders must
use clear communication techniques that allow discussions to flow freely at all levels of
the organization. Front-line practitioners must be included in all discussions on strategies
designed to improve safety.
Organizations need to completely eliminate professional silos in which each discipline
works independently, providing episodic care without coordination across providers.
“Silo” thinking has hindered the development of a team approach and has, thus, been at
the root of many medication errors. The inability to reconcile medications across the
continuum of healthcare continues to result in patient harm and death.
External Health Care Stakeholders
Regulatory, accrediting, and licensing bodies need to adopt safety standards as identified
by scientific research and expert committees, and provide oversight to healthcare
organization to ensure that they are fully implementing those safety standards.
The pharmaceutical industry should be held accountable for conducting pre-market
testing, using proactive risk management strategies such as failure mode and effects
analysis to detect potential labeling, packaging, or nomenclature problems. Postmarketing surveillance is also needed to detect adverse drug reactions and medication
error-related product problems. When errors are reported to the manufacturer, problems
should be fully disclosed to practitioners and changes should voluntarily be made to
ensure safety.
The manufacturers of medical devices and software should also be held accountable for
performing safety evaluations and for seeking expert advice about new products. They
must also freely disseminate information to healthcare providers (and consumers, when
appropriate) when design flaws in previously launched products are newly discovered.
Academia

On the academic front, educators should be accountable for weaving current medication
safety concepts throughout the entire curriculum so students can develop the critical
thinking skills necessary to manage patient safety.
Consumers
Patients can no longer be passive about their health care. They must see themselves as
active partners and not be intimidated by their practitioner’s disposition to ask questions
about their drug therapy. They should be informed that they are the last line of defense
from harm and must be proactive by providiing an accurate list of their medical history,
allergies, chronic conditions, medications, and other important medical information to
their healthcare providers.
Conclusion
Since no single stakeholder can sufficiently change a system, all health care stakeholders
must unite to prevent patient harm by sharing accountability for providing a safe
medication-use system. As Einstein stated, “Insanity is doing the same things the same
way and expecting different results.” Thus, significant improvements in medication
safety will not be make unless we change the way accountability is view and begin to
work together to finally design a medication-use system that is truly safe.
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